Inhibition of insulin-like growth factor-1 receptor signaling enhances growth-inhibitory and proapoptotic effects of gefitinib (Iressa) in human breast cancer cells
Anne Camirand(Jewish General Hospital), Michaël Pollak(Jewish General Hospital)
Cited by 121
Related Papers
Metformin Is an AMP Kinase–Dependent Growth Inhibitor for Breast Cancer Cells
|Cancer Research|2006|1k
Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth
|Endocrine Related Cancer|2008|184
Alterations in Cellular Energy Metabolism Associated with the Antiproliferative Effects of the ATM Inhibitor KU-55933 and with Metformin
|PLoS ONE|2012|37
Stimulation of MC38 tumor growth by insulin analog X10 involves the serine synthesis pathway
|Endocrine Related Cancer|2012|10